In short
Recurrent nasopharyngeal cancer presents a difficult challenge for patients and their care teams, with treatment options depending on where the cancer returns and what therapies were used initially.
What is Recurrent Nasopharyngeal Cancer
Recurrent nasopharyngeal cancer means that the cancer has come back after it has been treated. The nasopharynx is the upper part of the throat located behind the nose, where air passes on its way to the lungs.
Managing recurrent disease remains a challenging clinical problem. Between 15% and 58% of patients with nasopharyngeal cancer will experience recurrent disease and must undergo re-treatment. Treatment of this condition is considered a sequential challenge, as traditional treatments offer limited local control and survival benefits, and frequently cause severe late complications.
Patients who develop early recurrence, which refers to cancer that returns shortly after initial treatment, typically face worse survival outcomes compared to those with late recurrence.
When Recurrence Happens
The timing of when the cancer comes back can significantly impact a patient's outlook. After treatment with radiation therapy, the risk of cancer returning demonstrates a pattern over time, typically peaking sharply at 24 months before declining. Research shows that approximately 50% to 60% of nasopharyngeal cancer recurrences occur within this critical 24-month period.
Early recurrence is generally defined as cancer that returns within 24 months after completing initial treatment. This represents an important turning point in the disease. Patients with early recurrence have a notably short median overall survival, with one study finding it to be only 48.6 months. However, it is worth noting that tumor recurrence can occur even after five years, which is not uncommon in nasopharyngeal cancer.
Several factors appear to predict earlier recurrence. These include being male, having a more advanced tumor stage, having residual disease after treatment, detectable virus levels in the blood before and after radiation therapy, and not receiving induction chemotherapy, which is treatment given before the main therapy.
Treatment Options
Treatment options for recurrent nasopharyngeal cancer depend on where the cancer comes back and which treatments the patient received for the original cancer. The healthcare team will suggest treatments based on individual needs and work with patients to develop a treatment plan.
Chemoradiation
Chemoradiation combines chemotherapy with radiation therapy given during the same time period. The chemotherapy makes the radiation more effective. This treatment usually uses a drug called cisplatin, with or without fluorouracil or another drug, along with external radiation therapy.
Radiation Therapy
Radiation therapy may be offered for recurrent cancer. However, if a patient already received radiation to treat the original tumor, treating the same area with radiation again can cause more severe side effects. The radiation team will carefully plan treatment doses and schedules based on the amount of radiation previously used.
Different types of radiation therapy may be used. External radiation therapy is the type usually given for recurrent disease. Stereotactic radiosurgery, a very precise form of radiation, may also be given as a boost after external radiation therapy or chemoradiation. Brachytherapy, which involves placing radioactive material inside or near the tumor, may be used if external radiation was used to treat the original tumor. It can also be given as a boost to increase the amount of radiation delivered to the tumor.
Surgery
Surgery may be an option for tumors that come back in the same place as the original tumor. The goal is to remove the tumor. One type of surgery is called a nasopharyngectomy, which removes part of the nasopharynx.
A neck dissection removes the lymph nodes in the neck. This may be done if the cancer comes back in the lymph nodes. Other surgeries may be offered to relieve symptoms or provide supportive care for advanced cancer. These include placing a feeding tube to ensure adequate nutrition or placing a breathing tube to help with breathing.
Chemotherapy
Chemotherapy may be offered for recurrent cancer. Cancer that comes back in distant places in the body is usually treated with chemotherapy. Several different drugs may be used alone or in combination, including methotrexate, epirubicin, doxorubicin, paclitaxel, capecitabine, bleomycin, gemcitabine, docetaxel, cisplatin, and carboplatin.
Immunotherapy
Immunotherapy has emerged as a transformative approach to treating recurrent nasopharyngeal cancer. Immune checkpoint inhibitors, particularly drugs that target a protein called PD-1 or PD-L1, have shown promise. These treatments work by helping the body's immune system recognize and attack cancer cells.
In 2023, the drug toripalimab became the first immunotherapy approved by the U.S. Food and Drug Administration for treating nasopharyngeal cancer that has come back or spread to other parts of the body. Clinical trials showed that patients treated with toripalimab and chemotherapy lived longer overall and lived longer without their cancer getting worse than those who received chemotherapy alone.
Supportive Care
Patients may want to consider care focused on making them feel better without treating the cancer itself. This might be because cancer treatments no longer work, are unlikely to improve the condition, or may cause side effects that are hard to cope with. There may also be other reasons why patients cannot have or do not want cancer treatment.
Speech and swallowing therapists can help patients who have difficulty speaking or swallowing due to treatment effects. They can teach exercises to strengthen muscles in the tongue, mouth, throat, and voice box.
Regular dental care is important because radiation therapy can cause dry mouth and tooth decay. Nutritionists can help ensure patients get adequate nutrition, especially when swallowing is difficult.
The healthcare team can help patients choose appropriate care and treatment options for advanced cancer and provide support throughout the treatment journey.
